Erratum: Unraveling the associations of age and menopause with cardiovascular risk factors in a large population-based study [BMC Medicine 15, (2017) (74)] DOI: 10.1186/s12916-016-0762-8;Unraveling the associations of age and menopause with cardiovascular risk factors in a large population-based study

BMC Medicine

Volumn 15, Issue 1, 2017, Pages

  de Kat, A C ^a   Dam, V ^a   Onland Moret, N C ^a   Eijkemans, M J C ^a   Broekmans, F J M ^a   van der Schouw, Y T ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cardiovascular risk; Female aging; Menopause

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LIPID;

ADULT; AGING; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLIMACTERIUM; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; MENOPAUSE; MENSTRUAL CYCLE; POPULATION RESEARCH; POSTMENOPAUSE; PREMENOPAUSE; REPRODUCTIVE HEALTH; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SEXUAL BEHAVIOR; SYSTOLIC BLOOD PRESSURE; ADOLESCENT; AGED; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COHORT ANALYSIS; MIDDLE AGED; PHYSIOLOGY; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGING; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, LDL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LIPIDS; MENOPAUSE; MIDDLE AGED; PREMENOPAUSE; RISK FACTORS; YOUNG ADULT;

EID: 85010224338     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-017-0841-5     Document Type: Erratum

References (47)

1. van der Schouw YT, van der Graaf Y, Steyerberg EW, Eijkemans JC, Banga JD. Age at menopause as a risk factor for cardiovascular mortality. Lancet. 1996;347(9003):714-8.
2. Lisabeth LD, Beiser AS, Brown DL, Murabito JM, Kelly-Hayes M, Wolf PA. Age at natural menopause and risk of ischemic stroke: the Framingham heart study. Stroke. 2009;40(4):1044-9.
3. El Khoudary SR, Santoro N, Chen HY, Tepper PG, Brooks MM, Thurston RC, et al. Trajectories of estradiol and follicle-stimulating hormone over the menopause transition and early markers of atherosclerosis after menopause. Eur J Prev Cardiol. 2016;23(7):694-703.
4. Auro K, Joensuu A, Fischer K, Kettunen J, Salo P, Mattsson H, et al. A metabolic view on menopause and ageing. Nat Commun. 2014;5:4708.
5. Peters HW, Westendorp IC, Hak AE, Grobbee DE, Stehouwer CD, Hofman A, et al. Menopausal status and risk factors for cardiovascular disease. J Intern Med. 1999;246(6):521-8.
6. Matthews KA, Crawford SL, Chae CU, Everson-Rose SA, Sowers MF, Sternfeld B, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol. 2009;54(25):2366-73.
7. Kuh D, Langenberg C, Hardy R, Kok H, Cooper R, Butterworth S, et al. Cardiovascular risk at age 53 years in relation to the menopause transition and use of hormone replacement therapy: a prospective British birth cohort study. BJOG. 2005;112(4):476-85.
8. Casiglia E, Tikhonoff V, Boschetti G, Giordano N, Mazza A, Caffi S, et al. Arterial stiffness and related variables across menopausal status: an epidemiologic study. J Womens Health (Larchmt). 2013;22(1):75-84.
9. Son MK, Lim NK, Lim JY, Cho J, Chang Y, Ryu S, et al. Difference in blood pressure between early and late menopausal transition was significant in healthy Korean women. BMC Womens Health. 2015;15:64.
10. Anagnostis P, Stevenson JC, Crook D, Johnston DG, Godsland IF. Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractions. Maturitas. 2015;81(1):62-8.
11. Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause. 2006;13(2):265-79.
12. Vaidya D, Becker DM, Bittner V, Mathias RA, Ouyang P. Ageing, menopause, and ischaemic heart disease mortality in England, Wales, and the United States: modelling study of national mortality data. BMJ. 2011;343:d5170.
13. Appiah D, Schreiner PJ, Bower JK, Sternfeld B, Lewis CE, Wellons MF. Is surgical menopause associated with future levels of cardiovascular risk factor independent of antecedent levels? The CARDIA Study. Am J Epidemiol. 2015;182(12):991-9.
14. Bittner V. Menopause, age, and cardiovascular risk: a complex relationship. J Am Coll Cardiol. 2009;54(25):2374-5.
15. Sowers M, Zheng H, Tomey K, Karvonen-Gutierrez C, Jannausch M, Li X, et al. Changes in body composition in women over six years at midlife: ovarian and chronological aging. J Clin Endocrinol Metab. 2007;92(3):895-901.
16. Zanchetti A, Facchetti R, Cesana GC, Modena MG, Pirrelli A, Sega R, et al. Menopause-related blood pressure increase and its relationship to age and body mass index: the SIMONA epidemiological study. J Hypertens. 2005;23(12):2269-76.
17. Stolk RP, Rosmalen JG, Postma DS, de Boer RA, Navis G, Slaets JP, et al. Universal risk factors for multifactorial diseases: LifeLines: a three-generation population-based study. Eur J Epidemiol. 2008;23(1):67-74.
18. Scholtens S, Smidt N, Swertz MA, Bakker SJ, Dotinga A, Vonk JM, et al. Cohort Profile: LifeLines, a three-generation cohort study and biobank. Int J Epidemiol. 2015;44(4):1172-80.
19. Freeman EW, Sammel MD, Lin H, Boorman DW, Gracia CR. Contribution of the rate of change of antimullerian hormone in estimating time to menopause for late reproductive-age women. Fertil Steril. 2012;98(5):1254-9. e1-2.
20. Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, et al. Stages of Reproductive Aging Workshop (STRAW). J Womens Health Gend Based Med. 2001;10(9):843-8.
21. Slagter SN, van Vliet-Ostaptchouk JV, Vonk JM, Boezen HM, Dullaart RP, Kobold AC, et al. Combined effects of smoking and alcohol on metabolic syndrome: the LifeLines cohort study. PLoS One. 2014;9(4):e96406.
22. Gurrin LC, Scurrah KJ, Hazelton ML. Tutorial in biostatistics: spline smoothing with linear mixed models. Stat Med. 2005;24(21):3361-81.
23. Roshani D, Ghaderi E. Comparing smoothing techniques for fitting the nonlinear effect of covariate in Cox models. Acta Inform Med. 2016;24(1):38-41.
24. Zhang Z. Multiple imputation with multivariate imputation by chained equation (MICE) package. Ann Transl Med. 2016;4(2):30.
25. Clavel-Chapelon F. E3N-EPIC Group. Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women. Br J Cancer. 2002;86(5):723-7.
26. Staessen J, Bulpitt CJ, Fagard R, Lijnen P, Amery A. The influence of menopause on blood pressure. J Hum Hypertens. 1989;3(6):427-33.
27. Casiglia E, d'Este D, Ginocchio G, Colangeli G, Onesto C, Tramontin P, et al. Lack of influence of menopause on blood pressure and cardiovascular risk profile: a 16-year longitudinal study concerning a cohort of 568 women. J Hypertens. 1996;14(6):729-36.
28. Portaluppi F, Pansini F, Manfredini R, Mollica G. Relative influence of menopausal status, age, and body mass index on blood pressure. Hypertension. 1997;29(4):976-9.
29. van Beresteyn EC, Hof MA v t, De Waard H. Contributions of ovarian failure and aging to blood pressure in normotensive perimenopausal women: a mixed longitudinal study. Am J Epidemiol. 1989;129(5):947-55.
30. Bonithon-Kopp C, Scarabin PY, Darne B, Malmejac A, Guize L. Menopause-related changes in lipoproteins and some other cardiovascular risk factors. Int J Epidemiol. 1990;19(1):42-8.
31. de Aloysio D, Gambacciani M, Meschia M, Pansini F, Bacchi Modena A, Bolis PF, et al. The effect of menopause on blood lipid and lipoprotein levels. The Icarus Study Group. Atherosclerosis. 1999;147(1):147-53.
32. Abdulnour J, Doucet E, Brochu M, Lavoie JM, Strychar I, Rabasa-Lhoret R, et al. The effect of the menopausal transition on body composition and cardiometabolic risk factors: a Montreal-Ottawa New Emerging Team group study. Menopause. 2012;19(7):760-7.
33. He L, Tang X, Li N, Wu YQ, Wang JW, Li JR, et al. Menopause with cardiovascular disease and its risk factors among rural Chinese women in Beijing: a population-based study. Maturitas. 2012;72(2):132-8.
34. Chen Y, Zeleniuch-Jacquotte A, Arslan AA, Wojcik O, Toniolo P, Shore RE, et al. Endogenous hormones and coronary heart disease in postmenopausal women. Atherosclerosis. 2011;216(2):414-9.
35. Casanova G, Bossardi Ramos R, Ziegelmann P, Spritzer PM. Effects of low-dose versus placebo or conventional-dose postmenopausal hormone therapy on variables related to cardiovascular risk: a systematic review and meta-analyses of randomized clinical trials. J Clin Endocrinol Metab. 2015;100(3):1028-37.
36. Arca M, Vega GL, Grundy SM. Hypercholesterolemia in postmenopausal women. Metabolic defects and response to low-dose lovastatin. JAMA. 1994;271(6):453-9.
37. Ferrara CM, Lynch NA, Nicklas BJ, Ryan AS, Berman DM. Differences in adipose tissue metabolism between postmenopausal and perimenopausal women. J Clin Endocrinol Metab. 2002;87(9):4166-70.
38. Matthews KA, Abrams B, Crawford S, Miles T, Neer R, Powell LH, et al. Body mass index in mid-life women: relative influence of menopause, hormone use, and ethnicity. Int J Obes Relat Metab Disord. 2001;25(6):863-73.
39. Dorum A, Tonstad S, Liavaag AH, Michelsen TM, Hildrum B, Dahl AA. Bilateral oophorectomy before 50 years of age is significantly associated with the metabolic syndrome and Framingham risk score: a controlled, population-based study (HUNT-2). Gynecol Oncol. 2008;109(3):377-83.
40. Sutton-Tyrrell K, Zhao X, Santoro N, Lasley B, Sowers M, Johnston J, et al. Reproductive hormones and obesity: 9 years of observation from the Study of Women's Health Across the Nation. Am J Epidemiol. 2010;171(11):1203-13.
41. Gibson CJ, Thurston RC, El Khoudary SR, Sutton-Tyrrell K, Matthews KA. Body mass index following natural menopause and hysterectomy with and without bilateral oophorectomy. Int J Obes (Lond). 2013;37(6):809-13.
42. McCarthy AM, Menke A, Visvanathan K. Association of bilateral oophorectomy and body fatness in a representative sample of US women. Gynecol Oncol. 2013;129(3):559-64.
43. Harlow SD, Lin X, Ho MJ. Analysis of menstrual diary data across the reproductive life span applicability of the bipartite model approach and the importance of within-woman variance. J Clin Epidemiol. 2000;53(7):722-33.
44. Hodis HN, Mack WJ. The timing hypothesis and hormone replacement therapy: a paradigm shift in the primary prevention of coronary heart disease in women. Part 1: comparison of therapeutic efficacy. J Am Geriatr Soc. 2013;61(6):1005-10.
45. Cholesterol Treatment Trialists' (CTT) Collaboration, Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670-81.
46. Kim C, Cushman M, Khodneva Y, Lisabeth LD, Judd S, Kleindorfer DO, et al. Risk of incident coronary heart disease events in men compared to women by menopause type and race. J Am Heart Assoc. 2015;4(7):e001881.
47. Moreau KL, Hildreth KL. Vascular aging across the menopause transition in healthy women. Adv Vasc Med. 2014;2014:204390.